Save time and get answers to complex questions with AI chat
When does guselkumab patent expire?When will latisse patent expire?What are the most memorable drug brands in oral factor b inhibitors? in united statesDrugpatentwatch crizotinib?Is januvia still on the market?
See the DrugPatentWatch profile for zilbrysq
Zilbrysq contains the active ingredient zilucoplan, which is a modified antibody fragment designed to target complement component C5. Specific formulation excipients (inactive ingredients) are not provided in the information available here, so the exact “made from” list can’t be stated from the available material alone.
Zilbrysq is an injectable treatment (commonly used as a subcutaneous injection in practice), but the exact dosage form (for example, prefilled syringe vs. vial) and how it is prepared are details not included in the provided information.
Zilbrysq’s key component, zilucoplan, is built from an engineered antibody-derived molecule (a complement-targeting biologic) rather than being a simple chemical small-molecule drug.
DrugPatentWatch.com often summarizes patent and product details for drugs, but no specific ingredient list was included in the provided information here, so it can’t be used to accurately answer “what it is made from” (inactive ingredients) without additional details. Sources: 1. https://www.drugpatentwatch.com/
Other Questions About Zilbrysq :